Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 7:12 PM View:  | Beetham Thomas W. Chief Operating Officer | Viridian Therapeutics, Inc.... (VRDN) | 27-Sep-24 | Market Purchase | 5,000 | $23.41 | $117,050.00 | 500% 1.0K to 6.0K | (2%) |
| 30-Sep-24 7:10 PM View: | Mahoney Stephen F. President and CEO Director | Viridian Therapeutics, Inc.... (VRDN) | 27-Sep-24 | Market Purchase | 21,400 | $23.33 | $499,262.00 | 100% 0 to 21.4K | (1%) |
| 17-Sep-24 9:00 PM View: | Fairmount Funds Management ... Director 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 13-Sep-24 | Private Purchase | 1,600,000 | $18.75 | $30,000,000.00 | 87% 1.85M to 3.45M | |
| 01-Apr-24 6:32 PM View: | Fairmount Funds Management ... Director 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 28-Mar-24 | Acquisition (other) | 5,859 | -- | -- | < 1% 1.85M to 1.85M | |
| 01-Apr-24 6:32 PM View: | Fairmount Funds Management ... Director 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 28-Mar-24 | Disposition (other) | 5,859 | -- | -- | (< 1%) 1.85M to 1.85M | |
| 24-Jan-24 6:44 PM View: | Fairmount Funds Management ... Director 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 22-Jan-24 | Private Purchase | 476,190 | $21.00 | $9,999,990.00 | 35% 1.37M to 1.85M | |
| 12-Apr-23 7:05 PM View: | Myers Scott Dunseth Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 12-Apr-23 | Market Purchase | 4,000 | $25.37 | $101,479.00 | 2% 255.5K to 259.5K | (9%) |
| 13-Mar-23 4:06 PM View: | Myers Scott Dunseth Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 13-Mar-23 | Purchase | 5,500 | $29.15 | $160,324.00 | 2% 250.0K to 255.5K | |
| 10-Mar-23 4:05 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 09-Mar-23 | Private Sale (Planned) | 29,971 | $29.07 | $871,257.00 | (100%) 29.97K to 0 | |
| 07-Feb-23 6:55 PM View: | Myers Scott Dunseth Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 06-Feb-23 | Grant | 250,000 | -- | -- | 100% 0 to 250.0K | |
| 03-Feb-23 6:12 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 02-Feb-23 | Private Sale | 50,000 | $36.80 | $1,840,000.00 | (10%) 480.9K to 430.9K | |
| 25-Jan-23 6:04 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 23-Jan-23 | Option Exercise | 6,843 | $20.56 | $140,690.00 | 100% 0 to 6.84K | |
| 25-Jan-23 6:04 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 23-Jan-23 | Planned Option Sale | 6,843 | $35.66 | $244,021.00 | (100%) 6.84K to 0 | |
| 18-Jan-23 5:58 PM View: | Katz Barrett Chief Medical Officer | Viridian Therapeutics, Inc.... (VRDN) | 17-Jan-23 | Option Exercise | 24,853 | $23.03 | $572,365.00 | 100% 0 to 24.85K | |
| 18-Jan-23 5:58 PM View: | Katz Barrett Chief Medical Officer | Viridian Therapeutics, Inc.... (VRDN) | 17-Jan-23 | Planned Option Sale | 24,853 | $37.21 | $924,780.00 | (100%) 24.85K to 0 | |
| 18-Jan-23 5:58 PM View: | Katz Barrett Chief Medical Officer | Viridian Therapeutics, Inc.... (VRDN) | 13-Jan-23 | Planned Private Option Sale | 4,147 | $37.01 | $153,480.00 | (100%) 4.15K to 0 | |
| 18-Jan-23 5:58 PM View: | Katz Barrett Chief Medical Officer | Viridian Therapeutics, Inc.... (VRDN) | 13-Jan-23 | Option Exercise | 4,147 | $23.03 | $95,505.40 | 100% 0 to 4.15K | (< 1%) |
| 11-Jan-23 7:09 PM View: | Katz Barrett Chief Medical Officer | Viridian Therapeutics, Inc.... (VRDN) | 10-Jan-23 | Option Exercise | 47,377 | $23.03 | $1,091,090.00 | 100% 0 to 47.38K | |
| 11-Jan-23 7:09 PM View: | Katz Barrett Chief Medical Officer | Viridian Therapeutics, Inc.... (VRDN) | 10-Jan-23 | Planned Option Sale | 47,377 | $35.30 | $1,672,410.00 | (100%) 47.38K to 0 | |
| 11-Jan-23 7:09 PM View: | Katz Barrett Chief Medical Officer | Viridian Therapeutics, Inc.... (VRDN) | 09-Jan-23 | Option Exercise | 12,623 | $23.03 | $290,708.00 | 100% 0 to 12.62K | (< 1%) |
| 11-Jan-23 7:09 PM View: | Katz Barrett Chief Medical Officer | Viridian Therapeutics, Inc.... (VRDN) | 09-Jan-23 | Planned Private Option Sale | 12,623 | $33.04 | $417,064.00 | (100%) 12.62K to 0 | |
| 22-Dec-22 4:42 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 21-Dec-22 | Planned Option Sale | 16,326 | $29.19 | $476,556.00 | (100%) 16.33K to 0 | |
| 22-Dec-22 4:42 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 21-Dec-22 | Option Exercise | 16,326 | $23.03 | $375,988.00 | 100% 0 to 16.33K | |
| 22-Dec-22 4:42 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 20-Dec-22 | Planned Private Option Sale | 600 | $28.07 | $16,842.00 | (100%) 0.6K to 0 | |
| 22-Dec-22 4:42 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 20-Dec-22 | Option Exercise | 600 | $23.03 | $13,818.00 | 100% 0 to 0.6K | (< 1%) |
| 19-Dec-22 7:22 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 16-Dec-22 | Planned Option Sale | 1,297 | $28.44 | $36,886.70 | (100%) 1.3K to 0 | |
| 19-Dec-22 7:22 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 16-Dec-22 | Option Exercise | 1,297 | $23.03 | $29,869.90 | 100% 0 to 1.3K | |
| 19-Dec-22 7:22 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 15-Dec-22 | Planned Private Option Sale | 300 | $28.08 | $8,424.00 | (100%) 0.3K to 0 | |
| 19-Dec-22 7:22 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 15-Dec-22 | Option Exercise | 300 | $23.03 | $6,909.00 | 100% 0 to 0.3K | (< 1%) |
| 14-Dec-22 8:56 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 14-Dec-22 | Planned Option Sale | 15,656 | $28.12 | $440,247.00 | (100%) 15.66K to 0 | |
| 14-Dec-22 8:56 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 14-Dec-22 | Option Exercise | 15,656 | $23.03 | $360,558.00 | 100% 0 to 15.66K | |
| 14-Dec-22 8:56 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 12-Dec-22 | Planned Private Option Sale | 600 | $28.05 | $16,830.00 | (100%) 0.6K to 0 | |
| 14-Dec-22 8:56 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 12-Dec-22 | Option Exercise | 600 | $23.03 | $13,818.00 | 100% 0 to 0.6K | (< 1%) |
| 16-Nov-22 6:45 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 15-Nov-22 | Planned Option Sale | 8,125 | $22.05 | $179,156.00 | (100%) 8.13K to 0 | |
| 16-Nov-22 6:45 PM View: | Meisner Lara General Counsel and Secretary | Viridian Therapeutics, Inc.... (VRDN) | 15-Nov-22 | Option Exercise | 8,125 | $14.00 | $113,750.00 | 100% 0 to 8.13K | |
| 19-Aug-22 4:32 PM View: | Fairmount Funds Management ... Director 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 17-Aug-22 | Market Purchase | 425,531 | $23.50 | $9,999,980.00 | 45% 944.09K to 1.37M | (2%) |
| 02-Jun-22 5:29 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 01-Jun-22 | Sale | 30,000 | $12.20 | $366,000.00 | (6%) 510.9K to 480.9K | |
| 04-May-22 5:23 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 02-May-22 | Sale | 30,000 | $13.04 | $391,200.00 | (6%) 540.9K to 510.9K | |
| 05-Apr-22 6:09 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 04-Apr-22 | Sale | 3,600 | $18.93 | $68,148.00 | (< 1%) 544.5K to 540.9K | |
| 05-Apr-22 6:09 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 01-Apr-22 | Sale | 26,400 | $18.92 | $499,488.00 | (5%) 570.9K to 544.5K | |
| 03-Mar-22 4:48 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 02-Mar-22 | Sale | 11,106 | $17.36 | $192,800.00 | (2%) 582.01K to 570.9K | |
| 03-Mar-22 4:48 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 01-Mar-22 | Sale | 18,894 | $17.82 | $336,691.00 | (3%) 600.9K to 582.01K | |
| 03-Feb-22 6:11 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 03-Feb-22 | Sale | 909 | $19.16 | $17,416.40 | (< 1%) 601.81K to 600.9K | |
| 03-Feb-22 6:11 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 02-Feb-22 | Sale | 12,340 | $18.47 | $227,920.00 | (2%) 614.15K to 601.81K | |
| 03-Feb-22 6:11 PM View: | Violin Jonathan Chief Executive Officer Director | Viridian Therapeutics, Inc.... (VRDN) | 01-Feb-22 | Sale | 16,751 | $19.55 | $327,482.00 | (3%) 630.9K to 614.15K | |
| 10-Dec-21 6:08 PM View: | Violin Jonathan See Remarks Director | Viridian Therapeutics, Inc.... (VRDN) | 08-Dec-21 | Conversion | 627,564 | -- | -- | 18784% 3.34K to 630.9K | |
| 28-Sep-21 7:46 PM View: | Frazier Life Sciences Publi... 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 23-Sep-21 | Private Purchase | 200,000 | $11.00 | $2,200,000.00 | 15% 1.31M to 1.51M | |
| 23-Sep-21 10:00 PM View: | Fairmount Funds Management ... Director 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 21-Sep-21 | Private Purchase | 909,000 | $11.00 | $9,999,000.00 | 2590% 35.09K to 944.09K | |
| 16-Nov-20 6:23 PM View: | Logos Global Master Fund Lp 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 13-Nov-20 | Market Purchase | 126,667 | $14.84 | $1,879,600.00 | 30% 423.33K to 550.0K | 55% |
| 16-Nov-20 6:23 PM View: | Logos Global Master Fund Lp 10% Owner | Viridian Therapeutics, Inc.... (VRDN) | 09-Nov-20 | Market Purchase | 350,000 | $1.12 | $390,885.00 | 6% 6.0M to 6.35M | 38% |
